sulfinpyrazone has been researched along with Hypertension in 10 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Results of recent clinical trials on secondary prevention of ischemic heart disease indicate that judicious, long-term administration of adrenergic beta blockers and platelet-active drugs such as aspirin and Persantine (dipyridamole) would seem to yield protection against mortality associated with acute myocardial infarction, including sudden death." | 3.67 | Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases. ( Borhani, NO, 1985) |
| " Seven recently completed clinical trials, the Coronary Drug Project, the Aspirin Myocardial Infarction Study, the Anturane Reinfarction Trial, the Hypertension Detection and Follow-Up Program and three drug trials of betablockers, are reviewed from the perspective of both their clinical and methodological significance." | 3.66 | Overview of recent clinical and methodological advances from clinical trials of cardiovascular disease. ( Friedewald, WT; Schoenberger, JA, 1982) |
| "Gout is increasingly recognized as the most common form of inflammatory arthritis worldwide; however, no Canadian data on the disease burden of gout are available." | 1.46 | The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012. ( Aviña-Zubieta, JA; Choi, HK; De Vera, MA; McCormick, N; Rai, SK; Sayre, EC; Shojania, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rai, SK | 1 |
| Aviña-Zubieta, JA | 1 |
| McCormick, N | 1 |
| De Vera, MA | 1 |
| Shojania, K | 1 |
| Sayre, EC | 1 |
| Choi, HK | 1 |
| Marshall, AJ | 1 |
| Greco, R | 1 |
| Siciliano, S | 1 |
| Gentile, F | 1 |
| Elia, L | 1 |
| Murena, E | 1 |
| Forni, N | 1 |
| Boccalatte, A | 1 |
| Marsico, F | 1 |
| Friedewald, WT | 1 |
| Schoenberger, JA | 1 |
| Hinton, RC | 1 |
| Davi, G | 1 |
| Novo, S | 1 |
| Gullotti, D | 1 |
| Avellone, G | 1 |
| Sofia, MA | 1 |
| Strano, A | 1 |
| Borhani, NO | 1 |
| Ferrara, LA | 1 |
| Mancini, M | 1 |
| Marotta, T | 1 |
| Pasanisi, F | 1 |
| Fasano, ML | 1 |
| Günther, R | 1 |
| Knapp, E | 1 |
| Holländer, E | 1 |
| Schwarczmann, P | 1 |
1 review available for sulfinpyrazone and Hypertension
| Article | Year |
|---|---|
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; C | 1981 |
2 trials available for sulfinpyrazone and Hypertension
| Article | Year |
|---|---|
Sulfinpyrazone and platelet function in hypertensive patients.
Topics: Blood Platelets; Clinical Trials as Topic; Collagen; Female; Humans; Hypertension; Male; Middle Aged | 1984 |
Interference by sulphinpyrazone with the antihypertensive effects of oxprenolol.
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Drug Interacti | 1986 |
7 other studies available for sulfinpyrazone and Hypertension
| Article | Year |
|---|---|
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.
Topics: Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; British Columbia; Colchicine; Comorbidit | 2017 |
[Prevention of ischemic cardiopathy, with special reference to secondary prevention in the post-infarct period].
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Heart Failure; Humans; Hyperlipidemias; Hyperte | 1981 |
Overview of recent clinical and methodological advances from clinical trials of cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Di | 1982 |
Treatment of cerebral ischemia.
Topics: Aspirin; Brain Ischemia; Carotid Arteries; Dicumarol; Dipyridamole; Endarterectomy; Heart Murmurs; H | 1981 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; | 1985 |
[Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
Topics: Allopurinol; Diabetes Mellitus; Gout; Humans; Hypertension; Kidney Diseases; Male; Sulfinpyrazone; U | 1969 |
[Gout in advanced age].
Topics: Age Factors; Aged; Allopurinol; Bone and Bones; Cardiovascular Diseases; Colchicine; Female; Gout; H | 1968 |